Mark Zafereo is a Head & Neck physician affiliated with Texas Medical Center. OpenAlex indexes 331 publications with 9,708 citations (h-index 54); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Otolaryngology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Sponsor: M.D. Anderson Cancer Center
- Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
Sponsor: M.D. Anderson Cancer Center
Overall officialPhase 2Active, not recruitingNCT04759911 - Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
Sponsor: M.D. Anderson Cancer Center
Overall officialPhase 2Active, not recruitingNCT04675710
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
James Fleshman, MD
Texas Medical Center
Mihail Chelu, MD, PhD
Texas Medical Center
Anju Bhardwaj, MD
Texas Medical Center
Adan Rios, MD
Texas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”